Specify a stock or a cryptocurrency in the search bar to get a summary
Dawnrays Pharmaceutical Holdings Ltd
2348Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. Dawnrays Pharmaceutical (Holdings) Limited was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Address: CNT Tower, Wan Chai, Hong Kong
Analytics
WallStreet Target Price
21.4 HKDP/E ratio
3.0488Dividend Yield
6.38 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 2348
Dividend Analytics 2348
Dividend growth over 5 years
-35 %Continuous growth
3 yearsPayout Ratio 5 years average
35 %Dividend History 2348
Stock Valuation 2348
Financials 2348
Results | 2019 | Dynamics |